James Lord

7PUBLICATIONS
38CO-AUTHORS
AutoimmunityMolecular targetsNutrigenomics and personalised nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
UC-associated autoantibodies to αvβ6 inhibit mucosal TGFβ activation and predispose to intestinal inflammation.

Kayla J Fasano, Anna E Yoshida, Jane F Madden

|Mar 25, 2026
Filgotinib treatment modulates frequency and gene expression of circulating immune cell subsets in ulcerative colitis.

Emily R Wendt, Yan Liang, Grace Park

|Aug 25, 2025
Lessons from Prediction and Prevention of Type 1 Diabetes.

Cate Speake, Adam Lacy-Hulbert, James Lord

|Nov 03, 2023
Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire.

Andrew J Konecny, Donna M Shows, James D Lord

|Oct 19, 2023
Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.

Duncan C Hindmarch, Sofya Malashanka, Donna M Shows

|Oct 14, 2023
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells.

Elisa K Boden, Ramya Kongala, Duncan C Hindmarch

Pageof 2

Frequent Collaborators

2 joint publications

Cate Speake

1 joint publications

Oyebola O Oyesola

1 joint publications

Michael T Shanahan

1 joint publications

Matt Kanke